TAFLUPROST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tafluprost, and what generic alternatives are available?
Tafluprost is a drug marketed by Ingenus Pharms Llc, Micro Labs, and Sandoz. and is included in three NDAs.
The generic ingredient in TAFLUPROST is tafluprost. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tafluprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tafluprost
A generic version of TAFLUPROST was approved as tafluprost by MICRO LABS on August 19th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAFLUPROST?
- What are the global sales for TAFLUPROST?
- What is Average Wholesale Price for TAFLUPROST?
Summary for TAFLUPROST
Recent Clinical Trials for TAFLUPROST
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fondazione G.B. Bietti, IRCCS | Phase 4 |
| Tun Hussein Onn National Eye Hospital | Phase 4 |
| Taejoon Pharmaceutical Co., Ltd. | Phase 4 |
Pharmacology for TAFLUPROST
| Drug Class | Prostaglandin Analog |
| Mechanism of Action | Prostaglandin Receptor Agonists |
| Physiological Effect | Increased Prostaglandin Activity |
Anatomical Therapeutic Chemical (ATC) Classes for TAFLUPROST
Paragraph IV (Patent) Challenges for TAFLUPROST
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ZIOPTAN | Ophthalmic Solution | tafluprost | 0.0015% | 202514 | 2 | 2016-02-10 |
US Patents and Regulatory Information for TAFLUPROST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | TAFLUPROST | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 218002-001 | Apr 5, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Micro Labs | TAFLUPROST | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 209051-001 | Aug 19, 2019 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | TAFLUPROST | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 209040-001 | Jan 28, 2022 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
